Bioceltix S.A. (WSE: BCX)
Poland
· Delayed Price · Currency is PLN 74.20
+0.20 (0.27%)
Nov 20, 2024, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 365.40 million as of November 21, 2024. Its market cap has increased by 43.64% in one year.
Market Cap
365.40M
Enterprise Value
345.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
74.20
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 365.40M, an increase of 217.63%. That is a compound annual growth rate of 46.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 365.40M | -1.68% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krka, d. d. | 18.49B |
| NEUCA S.A. | 3.37B |
| Sopharma AD | 2.05B |
| Synektik Spólka Akcyjna | 1.45B |
| Celon Pharma S.A. | 1.42B |
| Voxel S.A. | 1.21B |
| Ryvu Therapeutics S.A. | 1.04B |
| Selvita S.A. | 974.68M |